This inventor holds 6 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: University of Southern California. Active years: 2011-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2022
Title: Innovations of Wei Li in Cancer Treatment
Introduction
Wei Li is an accomplished inventor based in Altadena, California. He has made significant contributions to the field of cancer treatment, holding a total of six patents. His work primarily focuses on developing compositions and methods that target specific cancer types, particularly those over-expressing HIF-1a.
Latest Patents
Wei Li's latest patents include innovative compositions and methods for treating HIF-1a over-expressing cancers. These patents describe monoclonal antibodies that specifically bind to Hsp90α, which are utilized in treating cancers such as breast cancer and lung cancer. The monoclonal antibodies target specific epitopes, including TKPIWTRNP and VKHFSVEGQ, in Hsp90α, providing a novel approach to cancer therapy.
Career Highlights
Wei Li is affiliated with the University of Southern California, where he continues to advance his research and development efforts. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from aggressive forms of cancer.
Collaborations
Some of Wei Li's notable coworkers include Mei Chen and David Woodley, who contribute to his research initiatives and collaborative projects.
Conclusion
Wei Li's innovative work in cancer treatment exemplifies the impact of targeted therapies in modern medicine. His contributions through patents and collaborations highlight the importance of research in combating complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile